Literature DB >> 20711061

Prion protein codon 129 polymorphism modifies age at onset of frontotemporal dementia with the C.709-1G>A progranulin mutation.

Fermín Moreno1, Ainhoa Alzualde, Pablo Martínez Camblor, Myriam Barandiaran, Vivianna M Van Deerlin, Alazne Gabilondo, José F Martí Massó, Adolfo López de Munain, Begoña Indakoetxea.   

Abstract

Frontotemporal lobar degeneration because of mutations in the progranulin (PGRN) gene presents a high variability both in the clinical phenotype and age of onset of disease. Factors that influence this variability remain largely unknown. The aim of our study was to determine whether selected genetic variables modify age at onset of disease in our series of 21 patients with a single splicing mutation (c.709-1G>A) in the PGRN gene, all of whom were of Basque descent. In our analysis, we included the following genetic variables: PGRN rs5848 and rs9897526 polymorphisms, APOE and microtubule-associated protein tau genotypes, and PRNP codon 129 polymorphism. We found no association between PGRN polymorphisms, APOE and microtubule-associated protein tau genotypes, and age at onset of the disease; whereas we report evidence for an association between PRNP codon 129 polymorphism and age at onset of disease in frontotemporal dementia-PGRN(+) patients. MM homozygous carriers presented onset of disease on average 8.5 years earlier than patients who carried at least 1 valine on their PRNP codon 129 (MV or VV). The biological justification for this association remains speculative.
Copyright © 2011 by Lippincott Williams & Wilkins

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20711061      PMCID: PMC3540994          DOI: 10.1097/WAD.0b013e3181eff695

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  10 in total

1.  Apolipoprotein E epsilon4 allele in familial and sporadic Parkinson's disease.

Authors:  L Blázquez; D Otaegui; A Sáenz; C Paisán-Ruiz; J I Emparanza; J Ruiz-Martinez; F Moreno; J F Martí-Massó; A López de Munain
Journal:  Neurosci Lett       Date:  2006-08-14       Impact factor: 3.046

2.  Association of an extended haplotype in the tau gene with progressive supranuclear palsy.

Authors:  M Baker; I Litvan; H Houlden; J Adamson; D Dickson; J Perez-Tur; J Hardy; T Lynch; E Bigio; M Hutton
Journal:  Hum Mol Genet       Date:  1999-04       Impact factor: 6.150

3.  Mutations in progranulin gene: clinical, pathological, and ribonucleic acid expression findings.

Authors:  Adolfo López de Munain; Ainhoa Alzualde; Ana Gorostidi; David Otaegui; Javier Ruiz-Martínez; Begoña Indakoetxea; Isidro Ferrer; Jordi Pérez-Tur; Amets Sáenz; Alberto Bergareche; Miriam Barandiarán; Juan José Poza; Ramón Zabalza; Irune Ruiz; Miguel Urtasun; Iñaki Fernández-Manchola; Bixen Olasagasti; Juan Bautista Espinal; Javier Olaskoaga; Marta Ruibal; Fermin Moreno; Nieves Carrera; José Félix Martí Massó
Journal:  Biol Psychiatry       Date:  2007-10-22       Impact factor: 13.382

4.  Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide.

Authors:  Luisa Benussi; Roberta Ghidoni; Eleonora Pegoiani; Davide V Moretti; Orazio Zanetti; Giuliano Binetti
Journal:  Neurobiol Dis       Date:  2008-12-06       Impact factor: 5.996

5.  "Frontotemporoparietal" dementia: clinical phenotype associated with the c.709-1G>A PGRN mutation.

Authors:  F Moreno; B Indakoetxea; M Barandiaran; A Alzualde; A Gabilondo; A Estanga; J Ruiz; M Ruibal; A Bergareche; J F Martí-Massó; A López de Munain
Journal:  Neurology       Date:  2009-10-27       Impact factor: 9.910

6.  The prion protein in human neurodegenerative disorders.

Authors:  Gabor G Kovacs; Pietro Zerbi; Till Voigtländer; Michaela Strohschneider; Gianriccardo Trabattoni; Johannes A Hainfellner; Herbert Budka
Journal:  Neurosci Lett       Date:  2002-09-06       Impact factor: 3.046

7.  Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration.

Authors:  Jennifer Gass; Ashley Cannon; Ian R Mackenzie; Bradley Boeve; Matt Baker; Jennifer Adamson; Richard Crook; Stacey Melquist; Karen Kuntz; Ron Petersen; Keith Josephs; Stuart M Pickering-Brown; Neill Graff-Radford; Ryan Uitti; Dennis Dickson; Zbigniew Wszolek; John Gonzalez; Thomas G Beach; Eileen Bigio; Nancy Johnson; Sandra Weintraub; Marsel Mesulam; Charles L White; Bryan Woodruff; Richard Caselli; Ging-Yuek Hsiung; Howard Feldman; Dave Knopman; Mike Hutton; Rosa Rademakers
Journal:  Hum Mol Genet       Date:  2006-09-01       Impact factor: 6.150

8.  Lack of TAR-DNA binding protein-43 (TDP-43) pathology in human prion diseases.

Authors:  A M Isaacs; C Powell; T E Webb; J M Linehan; J Collinge; S Brandner
Journal:  Neuropathol Appl Neurobiol       Date:  2008-08       Impact factor: 8.090

9.  A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series.

Authors:  Jonathan Beck; Jonathan D Rohrer; Tracy Campbell; Adrian Isaacs; Karen E Morrison; Emily F Goodall; Elizabeth K Warrington; John Stevens; Tamas Revesz; Janice Holton; Safa Al-Sarraj; Andrew King; Rachael Scahill; Jason D Warren; Nick C Fox; Martin N Rossor; John Collinge; Simon Mead
Journal:  Brain       Date:  2008-01-29       Impact factor: 13.501

10.  Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative.

Authors:  Rosa Rademakers; Matt Baker; Jennifer Gass; Jennifer Adamson; Edward D Huey; Parastoo Momeni; Salvatore Spina; Giovanni Coppola; Anna M Karydas; Heather Stewart; Nancy Johnson; Ging-Yuek Hsiung; Brendan Kelley; Karen Kuntz; Ellen Steinbart; Elisabeth McCarty Wood; Chang-En Yu; Keith Josephs; Eric Sorenson; Kyle B Womack; Sandra Weintraub; Stuart M Pickering-Brown; Peter R Schofield; William S Brooks; Vivianna M Van Deerlin; Julie Snowden; Christopher M Clark; Andrew Kertesz; Kevin Boylan; Bernardino Ghetti; David Neary; Gerard D Schellenberg; Thomas G Beach; Marsel Mesulam; David Mann; Jordan Grafman; Ian R Mackenzie; Howard Feldman; Thomas Bird; Ron Petersen; David Knopman; Bradley Boeve; Dan H Geschwind; Bruce Miller; Zbigniew Wszolek; Carol Lippa; Eileen H Bigio; Dennis Dickson; Neill Graff-Radford; Mike Hutton
Journal:  Lancet Neurol       Date:  2007-10       Impact factor: 44.182

  10 in total
  4 in total

Review 1.  Genetic prion diseases presenting as frontotemporal dementia: clinical features and diagnostic challenge.

Authors:  Zhongyun Chen; Min Chu; Li Liu; Jing Zhang; Yu Kong; Kexin Xie; Yue Cui; Hong Ye; Junjie Li; Lin Wang; Liyong Wu
Journal:  Alzheimers Res Ther       Date:  2022-06-29       Impact factor: 8.823

2.  Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene.

Authors:  Marka van Blitterswijk; Bianca Mullen; Aleksandra Wojtas; Michael G Heckman; Nancy N Diehl; Matthew C Baker; Mariely DeJesus-Hernandez; Patricia H Brown; Melissa E Murray; Ging-Yuek R Hsiung; Heather Stewart; Anna M Karydas; Elizabeth Finger; Andrew Kertesz; Eileen H Bigio; Sandra Weintraub; Marsel Mesulam; Kimmo J Hatanpaa; Charles L White; Manuela Neumann; Michael J Strong; Thomas G Beach; Zbigniew K Wszolek; Carol Lippa; Richard Caselli; Leonard Petrucelli; Keith A Josephs; Joseph E Parisi; David S Knopman; Ronald C Petersen; Ian R Mackenzie; William W Seeley; Lea T Grinberg; Bruce L Miller; Kevin B Boylan; Neill R Graff-Radford; Bradley F Boeve; Dennis W Dickson; Rosa Rademakers
Journal:  Mol Neurodegener       Date:  2014-09-20       Impact factor: 14.195

3.  Mutational analysis of PRNP in Alzheimer's disease and frontotemporal dementia in China.

Authors:  Weiwei Zhang; Bin Jiao; Tingting Xiao; Chuzheng Pan; Xixi Liu; Lin Zhou; Beisha Tang; Lu Shen
Journal:  Sci Rep       Date:  2016-12-02       Impact factor: 4.379

4.  Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study.

Authors:  Katrina M Moore; Jennifer Nicholas; Murray Grossman; Corey T McMillan; David J Irwin; Lauren Massimo; Vivianna M Van Deerlin; Jason D Warren; Nick C Fox; Martin N Rossor; Simon Mead; Martina Bocchetta; Bradley F Boeve; David S Knopman; Neill R Graff-Radford; Leah K Forsberg; Rosa Rademakers; Zbigniew K Wszolek; John C van Swieten; Lize C Jiskoot; Lieke H Meeter; Elise Gp Dopper; Janne M Papma; Julie S Snowden; Jennifer Saxon; Matthew Jones; Stuart Pickering-Brown; Isabelle Le Ber; Agnès Camuzat; Alexis Brice; Paola Caroppo; Roberta Ghidoni; Michela Pievani; Luisa Benussi; Giuliano Binetti; Bradford C Dickerson; Diane Lucente; Samantha Krivensky; Caroline Graff; Linn Öijerstedt; Marie Fallström; Håkan Thonberg; Nupur Ghoshal; John C Morris; Barbara Borroni; Alberto Benussi; Alessandro Padovani; Daniela Galimberti; Elio Scarpini; Giorgio G Fumagalli; Ian R Mackenzie; Ging-Yuek R Hsiung; Pheth Sengdy; Adam L Boxer; Howie Rosen; Joanne B Taylor; Matthis Synofzik; Carlo Wilke; Patricia Sulzer; John R Hodges; Glenda Halliday; John Kwok; Raquel Sanchez-Valle; Albert Lladó; Sergi Borrego-Ecija; Isabel Santana; Maria Rosário Almeida; Miguel Tábuas-Pereira; Fermin Moreno; Myriam Barandiaran; Begoña Indakoetxea; Johannes Levin; Adrian Danek; James B Rowe; Thomas E Cope; Markus Otto; Sarah Anderl-Straub; Alexandre de Mendonça; Carolina Maruta; Mario Masellis; Sandra E Black; Philippe Couratier; Geraldine Lautrette; Edward D Huey; Sandro Sorbi; Benedetta Nacmias; Robert Laforce; Marie-Pier L Tremblay; Rik Vandenberghe; Philip Van Damme; Emily J Rogalski; Sandra Weintraub; Alexander Gerhard; Chiadi U Onyike; Simon Ducharme; Sokratis G Papageorgiou; Adeline Su Lyn Ng; Amy Brodtmann; Elizabeth Finger; Rita Guerreiro; Jose Bras; Jonathan D Rohrer
Journal:  Lancet Neurol       Date:  2019-12-03       Impact factor: 44.182

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.